Home
Justin B. Klee, Co-CEO: Amylyx Pharmaceuticals AMLX Sell · Filed 23/01/10
Trade details
- Type
- Insider sale
- Amount
- $148,721.76
- Shares · price
- 4,122 sh · $36.08 a share
- Held after
- 2,894,463 sh
- Person
- Justin B. KleeCo-CEO
- Trade date
- 23/01/06
- Filed
- 23/01/10
- Days to filing
- 4 days
Sold 0.1% of holdings
- Share of holding sold
- 0.1%
Amylyx Pharmaceuticals trades, last 26 weeks
What else happened in Amylyx Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 22/12/07~23/02/05Justin B. Klee's recent trades
- Justin B. Klee
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$980.3K
30,464 sh
$980.3K
Filed 09/11
Traded 09/10
- Justin B. Klee
SellAmylyx Pharmaceuticals
SellAmylyx Pharmaceuticals
AMLX
$423.7K
29,282 sh
$423.7K
Filed 03/04
Traded 03/02
- Justin B. Klee
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$423.8K
29,282 sh
$423.8K
Filed 03/02
Traded 03/02
- Justin B. Klee
SellAmylyx Pharmaceuticals
SellAmylyx Pharmaceuticals
AMLX
$227.7K
15,500 sh
$227.7K
Filed 02/04
Traded 02/02
- Justin B. Klee
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$227.6K
15,500 sh
$227.6K
Filed 02/02
Traded 02/02